Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide Clinical Trials Resources presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, visits or professional assistance with a real medical. We aren't doctors. Always consult your mD about Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide Clinical research trials and Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide health trials occur in a lot of of places throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new does drugs. The role of the studies / projects is to resolve certain human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector corporations to detect remedies for all varieties of circumstances, such as Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide. Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide Clinical Trials and other clinical trials allow volunteers to obtain health treatment choices before they are available to the general public. Most times the human subjects recieve professional assistance for free of charge, and every now and again they are paid for their time. Sometimes there is a cost for a Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide clinical trial. Human subjects frequently get the finest healthcare available for their Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide condition. Risks are a reality, however, and may include extra or frequent physician visits, medical dangers (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with strict guidelines to protect clinical trials patients.

Home > "E" Clinical Trials Conditions > Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide

Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide



Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide

For Condition: Diabetes Mellitus, Non-Insulin-Dependent
Status: No longer recruiting
Sponsor(s): Amylin Pharmaceuticals ,
Synopsis: This is a randomized, single-blind, placebo-controlled, crossover study to examine the effect of pramlintide on the pharmacokinetics of an orally administered medication
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Single Blind, Placebo Control, Crossover Assignment, Pharmacokinetics Study
Minimum Age/Maximum Age: 18 Years/60 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Type 2 diabetes mellitus treated with diet and/or oral agents - HbA1c 6.5-11.0
Total Enrollment: 24

Location and Contact Information:

ICSL-Clinical Studies
Ft. Lauderdale,  Florida,  33301
United States
 


Additional Information:
Study ID Numbers:
  137-154; 
Study Start Date: August 2002
Record last reviewed: January 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00044707

Other Diabetes Mellitus, Non-Insulin-Dependent Studies:
1. The ORIGIN Trial (Outcome Reduction with Initial Glargine Intervention)

2. Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus

3. Disease Management and Educational Intervention Outcomes in High-Risk Diabetics

4. Safety and Efficacy of INGAP-Peptide in Patients with Type 2 Diabetes

5. Identification and therapy efficacy of Type 2 diabetes in Hispanic patients

Related Studies:

Other Diabetes Mellitus, Non-Insulin-Dependent Clinical Trials
Other Florida Clinical Trials
Other Ft. Lauderdale Clinical Trials

Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide

Modify your Search

  Other Diabetes Mellitus, Non-Insulin-Dependent Clinical Trials
  Other Florida Clinical Trials
  Other Ft. Lauderdale Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103